ARCHIVES

FASEB: Focus on Research Funding, Not PR

This article is from The Cancer Letter archive.

Vol. 39 No. 24 | June 14, 2013

Download PDF Visit The Full Archive

Related Articles

“Triple-Negative” Should Be Split Into Subtypes, Say Researchers

February 22, 2013

Reports Propose Stricter Rules To Protect Research Participants

October 11, 2002

Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease

June 29, 2012

UT Board Announces Support for MD Anderson Tenure System

October 10, 2014

DRCA Board Okays Concepts For Five Contract Projects

June 25, 1981

U.S., Canada Begin ExCel Trial To Evaluate Aromasin For Breast Cancer Prevention

April 29, 2005